|
JPH085107B2
(ja)
|
1988-08-04 |
1996-01-24 |
ファナック株式会社 |
電動式射出成形機における位置決め方式
|
|
IL91664A
(en)
|
1988-09-28 |
1993-05-13 |
Yissum Res Dev Co |
Ammonium transmembrane gradient system for efficient loading of liposomes with amphipathic drugs and their controlled release
|
|
CA2136324A1
(en)
|
1992-07-08 |
1994-01-20 |
Steven Joseph Brickner |
5'-indolinyl oxazolidinones useful against mycobacterium tuberculosis
|
|
JPH0873455A
(ja)
|
1994-03-15 |
1996-03-19 |
Upjohn Co:The |
オキサゾリジノン誘導体及びこれを有効成分とする医薬組成物
|
|
US5800833A
(en)
|
1995-02-27 |
1998-09-01 |
University Of British Columbia |
Method for loading lipid vesicles
|
|
CA2269758C
(en)
|
1996-10-22 |
2008-01-08 |
Hermes Biosciences, Inc. |
Liposome compositions comprising ionizable compounds in stable precipitated form and methods for their preparation
|
|
AU5889701A
(en)
|
2000-06-05 |
2001-12-17 |
Dong A Pharm Co Ltd |
Novel oxazolidinone derivatives and a process for the preparation thereof
|
|
WO2003008389A1
(en)
|
2001-07-16 |
2003-01-30 |
Ranbaxy Laboratories Limited |
Oxazolidinone derivatives as potential antimicrobials
|
|
HUP0302918A2
(hu)
|
2000-07-17 |
2003-12-29 |
Ranbaxy Laboratories Limited |
Mikrobaellenes oxazolidinonszármazékok és a vegyületeket tartalmazó gyógyászati készítmények és eljárás a vegyületek előállítására
|
|
AU2002331481B2
(en)
|
2001-10-03 |
2008-04-24 |
Celator Pharmaceuticals, Inc. |
Liposome loading with metal ions
|
|
JP2005530704A
(ja)
*
|
2002-03-05 |
2005-10-13 |
トランセイブ， インク． |
細胞内感染を予防及び治療するための吸入システム
|
|
JP2005529924A
(ja)
|
2002-05-15 |
2005-10-06 |
ランバクシー ラボラトリーズ リミテッド |
フェニルオキサゾリジノン誘導体
|
|
BR0215921A
(pt)
|
2002-07-29 |
2005-09-13 |
Ranbaxy Lab Ltd |
Derivados de oxazolidinona utilizáveis como antimicrobianos e processo de sua preparação
|
|
WO2004048350A2
(en)
|
2002-11-28 |
2004-06-10 |
Astrazeneca Ab |
Oxazolidinones as antibacterial agents
|
|
GB0229518D0
(en)
|
2002-12-19 |
2003-01-22 |
Astrazeneca Ab |
Chemical compounds
|
|
WO2004099199A1
(en)
|
2003-05-06 |
2004-11-18 |
Ranbaxy Laboratories Limited |
Oxazolidinone derivatives as antimicrobials
|
|
US8324398B2
(en)
|
2003-06-03 |
2012-12-04 |
Rib-X Pharmaceuticals, Inc. |
Process for the synthesis of biaryl oxazolidinones
|
|
EP1656370B1
(en)
|
2003-06-03 |
2012-08-15 |
Rib-X Pharmaceuticals, Inc. |
Biaryl heterocyclic compounds and methods of making and using the same
|
|
KR100854211B1
(ko)
|
2003-12-18 |
2008-08-26 |
동아제약주식회사 |
신규한 옥사졸리디논 유도체, 그의 제조방법 및 이를유효성분으로 하는 항생제용 약학 조성물
|
|
WO2005082899A1
(en)
|
2004-01-28 |
2005-09-09 |
Ranbaxy Laboratories Limited |
Oxazolidinone derivatives as antimicrobials
|
|
LT3173073T
(lt)
|
2004-05-03 |
2025-01-10 |
Ipsen Biopharm Ltd. |
Liposomos, skirtos vaistų pristatymui
|
|
CA2567929A1
(en)
|
2004-05-25 |
2005-12-08 |
Astrazeneca Ab |
3- {4- (pyridin-3-yl) phenyl} -5- (1h-1, 2, 3-triazol-1-ylmethyl) -1, 3-oxazolidin-2-ones as antibacterial agents
|
|
JP2008500317A
(ja)
|
2004-05-25 |
2008-01-10 |
アストラゼネカ アクチボラグ |
抗菌剤としての３−’４−｛６−置換アルカノイル）ピリジン−３−イル｝−３−フェニル−５−（１ｈ−１，２，３−トリアゾール−１−イルメチル）−１，３−オキサゾリジン−２−オン
|
|
WO2006035283A1
(en)
|
2004-09-27 |
2006-04-06 |
Ranbaxy Laboratories Limited |
Oxazolidinone derivatives as antimicrobials
|
|
WO2006037230A1
(en)
|
2004-10-06 |
2006-04-13 |
Bc Cancer Agency |
Liposomes with improved drug retention for treatment of cancer
|
|
WO2006051408A1
(en)
|
2004-11-11 |
2006-05-18 |
Ranbaxy Laboratories Limited |
Oxazolidinone derivatives as antimicrobials
|
|
EP1745784A1
(en)
|
2005-06-27 |
2007-01-24 |
Ferrer Internacional, S.A. |
Oxazolidinone derivatives and use thereof as antibiotics
|
|
EP3067047B1
(en)
*
|
2005-12-08 |
2022-04-20 |
Insmed Incorporated |
Lipid-based compositions of antiinfectives for treating pulmonary infections
|
|
KR101023174B1
(ko)
|
2008-09-24 |
2011-03-18 |
주식회사 레고켐 바이오사이언스 |
사이클릭 아미독심 또는 사이클릭 아미드라존 기를 가지는 신규한 옥사졸리디논 유도체 및 이를 함유하는 의약 조성물
|
|
RU2659792C1
(ru)
|
2008-10-10 |
2018-07-04 |
Мерк Шарп Энд Домэ Корп. |
Оксазолидиноны и способ их очистки
|
|
MY156354A
(en)
|
2009-02-03 |
2016-02-15 |
Merck Sharp & Dohme |
Crystalline form of r)-3-(4-(2-(2-methyltetrazol-5-yl)pyridin-5-yl)-3-fluorophenyl)-5-hydroxymethyl oxazolidin-2-one dihydrogen phosphate
|
|
US8580767B2
(en)
|
2009-05-28 |
2013-11-12 |
Trius Therapeutics, Inc. |
Oxazolidinone containing dimer compounds, compositions and methods to make and use
|
|
WO2012033952A1
(en)
|
2010-09-10 |
2012-03-15 |
Micurx Pharmaceuticals, Inc. |
3 - phenyl- 2 -oxo- 1, 3 -oxazolidines for treatment of bacterial infections
|
|
UA112876C2
(uk)
|
2011-09-29 |
2016-11-10 |
Сюаньчжу Фарма Ко., Лтд. |
Біарилгетероциклзаміщені оксазолідинонові антибактеріальні засоби
|
|
WO2016009401A2
(en)
|
2014-07-18 |
2016-01-21 |
Dr. Reddy's Laboratories Limited |
Preparation of tedizolid phosphate
|
|
CN104496979A
(zh)
|
2014-09-17 |
2015-04-08 |
博瑞生物医药技术(苏州)有限公司 |
一种噁唑烷酮类化合物及其中间体的制备方法
|
|
WO2016041505A1
(zh)
|
2014-09-17 |
2016-03-24 |
正大天晴药业集团股份有限公司 |
一种磷酸特地唑胺、其中间体以及它们的制备方法
|
|
CN104327119A
(zh)
|
2014-10-17 |
2015-02-04 |
苏州明锐医药科技有限公司 |
磷酸泰地唑胺的制备方法
|
|
WO2016088101A1
(en)
|
2014-12-05 |
2016-06-09 |
Sun Pharmaceutical Industries Limited |
Processes for the preparation of tedizolid phosphate and its intermediates
|
|
WO2016088102A1
(en)
|
2014-12-05 |
2016-06-09 |
Sun Pharmaceutical Industries Limited |
Processes for the preparation of tedizolid phosphate and its intermediates
|
|
WO2016088100A1
(en)
|
2014-12-05 |
2016-06-09 |
Sun Pharmaceutical Industries Limited |
Processes for the preparation of tedizolid phosphate and its intermediates
|
|
WO2016088103A1
(en)
|
2014-12-05 |
2016-06-09 |
Sun Pharmaceutical Industries Limited |
A process for the preparation of tedizolid phosphate
|
|
CN108472284A
(zh)
|
2015-09-11 |
2018-08-31 |
维纳拓尔斯制药公司 |
β-内酰胺酶抑制剂
|
|
EP4647126A3
(en)
|
2015-10-16 |
2026-02-11 |
Ipsen Biopharm Ltd. |
Stabilizing camptothecin pharmaceutical compositions
|
|
WO2017066964A1
(en)
|
2015-10-22 |
2017-04-27 |
Merck Sharp & Dohme Corp. |
Oxazolidinone compounds and methods of use thereof as antibacterial agents
|
|
CN106632298B
(zh)
|
2015-11-03 |
2021-06-01 |
上海科胜药物研发有限公司 |
一种泰地唑胺的制备方法及其中间体
|
|
KR101855334B1
(ko)
|
2015-12-11 |
2018-06-08 |
에스티팜 주식회사 |
옥사졸리디논 유도체의 중간체 제조방법
|
|
WO2017100925A1
(en)
|
2015-12-15 |
2017-06-22 |
British Columbia Cancer Agency Branch |
Metal complexed therapeutic agents and lipid-based nanoparticulate formulations thereof
|
|
MX2018008507A
(es)
|
2016-01-11 |
2019-07-04 |
Merrimack Pharmaceuticals Inc |
Inhibición de proteína relacionada con ataxia telangiectasia y rad3 (atr).
|
|
US11040025B2
(en)
|
2016-02-17 |
2021-06-22 |
The Johns Hopkins University |
Oxazolidinone for treatment of infections with Mycobacterium tuberculosis
|
|
WO2018170664A1
(en)
|
2017-03-20 |
2018-09-27 |
Merck Sharp & Dohme Corp. |
Oxazolidinone compounds and methods of use thereof as antibacterial agents
|
|
WO2020021468A1
(en)
|
2018-07-25 |
2020-01-30 |
Cadila Healthcare Limited |
Substituted oxazolidinones for the treatment of mammalian infections
|
|
WO2020147504A1
(en)
|
2019-01-18 |
2020-07-23 |
Merck Sharp & Dohme Corp. |
Oxazolidinone compounds and methods of use thereof as antibacterial agents
|
|
WO2021184339A1
(en)
|
2020-03-20 |
2021-09-23 |
Merck Sharp & Dohme Corp. |
Oxazolidinone compound and methods of use thereof as an antibacterial agent
|
|
CA3183397A1
(en)
|
2020-06-18 |
2021-12-23 |
Daryl C. Drummond |
Oxazolidinone compounds, liposome compositions comprising oxazolidinone compounds and methods of use thereof
|